Table 1.
Frequency of prostate cancers by detection mode (PSA detected or clinical), stage (localised or advanced), Gleason score (GS) categories (<7 or ≥7) and age groups, in men 50-69 years with prostate cancer diagnosis between 2002 and 2005
| Age group | ||||||||
|---|---|---|---|---|---|---|---|---|
| 50-54 | 55-59 | 60-64 | 65-69 | |||||
| N | (%) | N | (%) | N | (%) | N | (%) | |
| PSA tested | 12092 | 13787 | 10060 | 7903 | ||||
| PSA detected Cancers * | 134 | (100) | 344 | (100) | 487 | (100) | 549 | (100) |
| Localised cancers | 125 | (93) | 310 | (90) | 428 | (88) | 459 | (84) |
| Advanced cancers | 9 | (7) | 34 | (10) | 59 | (12) | 90 | (16) |
| Gleason Score <7 | 100 | (75) | 259 | (75) | 354 | (73) | 358 | (65) |
| Gleason Score ≥7 | 34 | (25) | 85 | (25) | 133 | (27) | 191 | (35) |
| Localised & GS<7 | 99 | (74) | 246 | (71) | 342 | (70) | 338 | (61) |
| Localised & GS ≥7 | 26 | (19) | 64 | (19) | 86 | (18) | 121 | (22) |
| Advanced & GS <7 | 1 | (0) | 13 | (4) | 12 | (2) | 20 | (4) |
| Advanced & GS ≥7 | 8 | (6) | 21 | (6) | 47 | (10) | 70 | (13) |
| Clinically diagnosed cancers † | 128 | (100) | 352 | (100) | 605 | (100) | 936 | (100) |
| Localised cancers | 96 | (75) | 279 | (79) | 458 | (76) | 698 | (75) |
| Advanced cancers | 32 | (25) | 73 | (21) | 147 | (24) | 238 | (25) |
| Gleason Score <7 | 65 | (49) | 172 | (49) | 263 | (43) | 401 | (43) |
| Gleason Score ≥7 | 63 | (51) | 180 | (51) | 342 | (57) | 535 | (57) |
| Localised & GS <7 | 61 | (48) | 162 | (46) | 242 | (40) | 362 | (39) |
| Localised & GS ≥7 | 35 | (27) | 117 | (33) | 216 | (36) | 336 | (36) |
| Advanced & GS <7 | 4 | (3) | 10 | (3) | 21 | (3) | 39 | (4) |
| Advanced & GS ≥7 | 28 | (22) | 63 | (18) | 126 | (21) | 199 | (21) |
*
PSA detected cancers were identified from ProtecT study
†
Clinically diagnosed cancers were identified from ECRIC